Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
about
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodiesBorder Patrol Gone Awry: Lung NKT Cell Activation by Francisella tularensis Exacerbates Tularemia-Like DiseaseDevelopment of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.Tularemia vaccine development: paralysis or progress?An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy.Lack of OxyR and KatG Results in Extreme Susceptibility of Francisella tularensis LVS to Oxidative Stress and Marked Attenuation In vivo.Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals.Inclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent Francisella tularensisProgress, challenges, and opportunities in Francisella vaccine development.Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.The Ability to Acquire Iron Is Inversely Related to Virulence and the Protective Efficacy of Francisella tularensis Live Vaccine Strain.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
P2860
Q28831290-332227CD-F545-4152-A94E-97DDD67F16CFQ35661972-4FCCDC4A-EE50-4554-9F5F-609EF347725FQ35670540-1E02156B-1B81-4EDA-900F-A61C0D561E35Q36908692-EEA34F36-6312-4F10-BB7F-3BE9F65090FDQ37438123-6C6A6480-726F-43E9-B108-D30F21C9FF44Q37601346-ECEAF64D-93AE-4E73-996C-9043B6706474Q38687410-6564171F-DCBE-41D5-BCDF-3B005F66289AQ39471468-65149898-0426-4EEE-8543-5AC426CFDEE8Q39892106-6A84DBE3-5487-4540-AAB4-11E4C5026CB0Q40093204-B2169F53-3BC4-443E-BF51-BA18AC66BBE5Q40557637-5B9EB18E-1CD3-45C1-BD85-58F865DC333EQ47239165-5BBDA23D-2094-4C1D-9D60-BB4B831F244FQ50329805-75DA1033-7942-402E-9DD0-DDDB89293EC3Q52571082-B0A4BD1D-AECF-41C8-B6D8-E730C7720289Q52725623-0BDC2419-D0B4-4261-AEDE-6BC1127B07DDQ55267074-3297C801-63CF-4A7C-9F39-1CC42D306468Q55361721-3B6FCA59-E06F-4996-8A7A-DF2E7A68C985
P2860
Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Successful protection against ...... sis-specific effector T cells.
@ast
Successful protection against ...... sis-specific effector T cells.
@en
Successful protection against ...... sis-specific effector T cells.
@nl
type
label
Successful protection against ...... sis-specific effector T cells.
@ast
Successful protection against ...... sis-specific effector T cells.
@en
Successful protection against ...... sis-specific effector T cells.
@nl
prefLabel
Successful protection against ...... sis-specific effector T cells.
@ast
Successful protection against ...... sis-specific effector T cells.
@en
Successful protection against ...... sis-specific effector T cells.
@nl
P2093
P2860
P356
P1476
Successful protection against ...... sis-specific effector T cells.
@en
P2093
Amanda J Griffin
Catharine M Bosio
Deborah D Crane
Tara D Wehrly
P2860
P304
P356
10.1128/CVI.00648-14
P577
2014-11-19T00:00:00Z